Human coronavirus NL63, France

Emerg Infect Dis. 2005 Aug;11(8):1225-9. doi: 10.3201/eid1108.050110.

Abstract

The human coronavirus NL63 (HCoV-NL63) was first identified in The Netherlands, and its circulation in France has not been investigated. We studied HCoV-NL63 infection in hospitalized children diagnosed with respiratory tract infections. From November 2002 to April 2003, we evaluated 300 respiratory specimens for HCoV-NL63. Of the 300 samples, 28 (9.3%) were positive for HCoV-NL63. The highest prevalence was found in February (18%). The main symptoms were fever (61%), rhinitis (39%), bronchiolitis (39%), digestive problems (33%), otitis (28%), pharyngitis (22%), and conjunctivitis (17%). A fragment of the spike protein gene was sequenced to determine the variety of circulating HCoV-NL63. Phylogenetic analysis indicated that strains with different genetic markers cocirculate in France.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amino Acid Sequence
  • Base Sequence
  • Child
  • Child, Preschool
  • Coronavirus / genetics
  • Coronavirus / isolation & purification*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / virology*
  • France / epidemiology
  • Humans
  • Infant
  • Phylogeny
  • RNA, Viral / chemistry
  • RNA, Viral / genetics
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / virology*
  • Retrospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Alignment
  • Sequence Analysis, DNA

Substances

  • RNA, Viral